|
Journal of Zhejiang University SCIENCE B
ISSN 1673-1581(Print), 1862-1783(Online), Monthly
2017 Vol.18 No.1 P.37-47
Haplotype of platelet receptor P2RY12 gene is associated with residual clopidogrel on-treatment platelet reactivity
Abstract: Objective: To investigate a possible association between common variations of the P2RY12 and the residual clopidogrel on-treatment platelet reactivity after adjusting for the influence of CYP2C19 tested by thromboelastography (TEG). Methods: One hundred and eighty patients with acute coronary syndrome (ACS) treated with clopidogrel and aspirin were included and platelet function was assessed by TEG. Five selected P2RY12 single nucleotide polymorphisms (SNPs; rs6798347, rs6787801, rs6801273, rs6785930, and rs2046934), which cover the common variations in the P2RY12 gene and its regulatory regions, and three CYP2C19 SNPs (*2,*3,*17) were genotyped and possible haplotypes were analyzed. Results: The high on-treatment platelet reactivity (HTPR) prevalence defined by a platelet inhibition rate <30% by TEG in adenosine diphosphate (ADP)-channel was 69 (38.33%). Six common haplotypes were inferred from four of the selected P2RY12 SNPs (denoted H0 to H5) according to the linkage disequilibrium R square (except for rs2046934). Haplotype H1 showed a significantly lower incidence of HTPR than the reference haplotype (H0) in the total study population while haplotypes H1 and H2 showed significantly lower incidences of HTPR than H0 in the nonsmoker subgroup after adjusting for CYP2C19 effects and demographic characteristics. rs2046934 (T744C) did not show any significant association with HTPR. Conclusions: The combination of common P2RY12 variations including regulatory regions rather than rs2046934 (T744C) that related to pharmacodynamics of clopidogrel in patients with ACS was independently associated with residual on-clopidogrel platelet reactivity. This is apart from the established association of the CYP2C19. This association seemed more important in the subgroup defined by smoking.
Key words: P2RY12, CYP2C19, Haplotype, Single nucleotide polymorphism (SNP), Clopidogrel, Thromboelastography
创新点:首次在ä¸å›½äººç¾¤ä¸å¯¹åŒ…å«è°ƒæŽ§åŸºå› 在内的五个常è§P2RY12çªå˜ä½ç‚¹è¿›è¡Œå•å€ä½“分æžï¼Œå¹¶ä¸”æ ¡æ£äº†CYP2C19åŸºå› å¤šæ€æ€§çš„å½±å“,å‘现P2RY12常è§åŸºå› ä½ç‚¹è”åˆçªå˜å¯é™ä½Žæ°¯å¡æ ¼é›·ç”¨è¯åŽè¡€å°æ¿é«˜å应性å‘生率,且作用在ä¸å¸çƒŸäººç¾¤ä¸æ›´æ˜Žæ˜¾ã€‚
方法:连ç»å…¥é€‰180例接å—æ°¯å¡æ ¼é›·è¯ç‰©æ²»ç–—çš„æ€¥æ€§å† è„‰ç»¼åˆå¾æ‚£è€…ï¼Œåˆ©ç”¨è¡€æ “å¼¹åŠ›å›¾æ³•æ£€æµ‹æ‚£è€…ç”¨è¯åŽè¡€å°æ¿å应性,将用è¯åŽè¡€å°æ¿æŠ‘制率<30%定义为血å°æ¿é«˜å应性(HTPR)。用多é‡è¿žæŽ¥é…¶æ£€æµ‹å应(LDR)技术,对覆盖P2RY12è°ƒæŽ§åŸºå› åœ¨å†…çš„äº”ä¸ªåŸºå› ä½ç‚¹ï¼ˆrs6798347〠rs6787801ã€rs6801273ã€rs6785930å’Œrs2046934)以åŠCYP2C19常è§çš„三个ç‰ä½åŸºå› (*2ã€*3å’Œ*17ï¼‰è¿›è¡ŒåŸºå› åˆ†åž‹ã€‚æ ¹æ®è¿žé”ä¸å¹³è¡¡ç³»æ•°å’ŒåŸºå› 分布频率进行å•å€ä½“分æžï¼Œè§‚å¯Ÿåœ¨æ ¡æ£CYP2C19åŸºå› å¤šæ€æ€§å½±å“åŽï¼Œä¸åŒP2RY12å•å€ä½“分型对氯å¡æ ¼é›·ç”¨è¯åŽHTPRçš„å½±å“。
结论:将P2RY12åŸºå› rs6798347ã€rs6787801ã€rs6801273å’Œrs6785930四个紧密连é”çš„å•æ ¸è‹·é…¸å¤šæ€æ€§ï¼ˆSNP)分为å…个常è§å•å€ä½“分æžï¼ˆH0~H5,表4)。å•å€ä½“分型与氯å¡æ ¼é›·ç”¨è¯åŽHTPRå‘生率显著相关,与H0型相比,H1åž‹HTPRå‘生率显著é™ä½Žï¼Œè€Œrs2046934对HTPRå‘ç”ŸçŽ‡æ— æ˜¾è‘—å½±å“(表5),且在ä¸å¸çƒŸç»„ä¸å•å€ä½“分型对HTPRå½±å“更明显(图1)。综上所述,P2RY12åŸºå› rs6798347ã€rs6787801ã€rs6801273å’Œrs6785930å•å€ä½“分型与氯å¡æ ¼é›·ç”¨è¯åŽHTPR显著相关。
关键è¯ç»„:
References:
Open peer comments: Debate/Discuss/Question/Opinion
<1>
DOI:
10.1631/jzus.B1600333
CLC number:
R543.3
Download Full Text:
Downloaded:
3055
Download summary:
<Click Here>Downloaded:
2015Clicked:
4509
Cited:
0
On-line Access:
2024-08-27
Received:
2023-10-17
Revision Accepted:
2024-05-08
Crosschecked:
2016-12-14